Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab

por Law, Jennie Y, Kim, Dong W, Sturgis, Ariel, Naina, Harris V
Publicado en Clin Med Insights Oncol (2015)

An Electronic Teaching Module for Improving Knowledge of Self-Management of Vaso-Occlusive Pain Crises in Patients With Sickle Cell Disease: Pilot Questionnaire Study

por Tam, Tammie, Baer, Maria R, Hsu, Lewis L, Law, Jennie Y
Publicado en JMIR Mhealth Uhealth (2019)

Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.

por Adige, Sunil, Lapidus, Rena G., Carter-Cooper, Brandon A., Duffy, Alison, Patzke, Ciera, Law, Jennie Y., Baer, Maria R., Ambulos, Nicholas P., Zou, Ying, Bentzen, Søren M., Emadi, Ashkan
Publicado en Cancer Chemother Pharmacol (2019)

Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma

por Fowler, Nathan H., Samaniego, Felipe, Jurczak, Wojciech, Ghosh, Nilanjan, Derenzini, Enrico, Reeves, James A., Knopińska-Posłuszny, Wanda, Cheah, Chan Y., Phillips, Tycel, Lech-Maranda, Ewa, Cheson, Bruce D., Caimi, Paolo F., Grosicki, Sebastian, Leslie, Lori A., Chavez, Julio C., Fonseca, Gustavo, Babu, Sunil, Hodson, Daniel J., Shao, Spencer H., Burke, John M., Sharman, Jeff P., Law, Jennie Y., Pagel, John M., Miskin, Hari P., Sportelli, Peter, O'Connor, Owen A., Weiss, Michael S., Zinzani, Pier Luigi
Publicado en J Clin Oncol (2021)